abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Operating Cash Flow (Statement)
-$3.54M
TTM · Period ending: · USD
HQL Operating Cash Flow (Statement)
Latest reported-$3.54Mperiod ending
Latest reported-$3.54Mperiod ending
HQL TTM Cash from Operations (-$3.00M → -$3.54M)
TTM operating cash flow (statement)
High-resolution chart · PNG
HQL operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -3,539,787 | |
| -2,320,285 | |
| -1,044,926 | |
| 0 | |
| -0 | |
| -1 | |
| -1 | |
| -1 | |
| -1 | |
| -1 | |
| -1 | |
| -1 | |
| -0 | |
| 0 | |
| 0 | |
| 0 | |
| -45,810 | |
| 0 | |
| -58,613 | |
| -52,565 | |
| -1,682 | |
| -45,293 | |
| 4,124,687 | |
| 21,112,371 | |
| 80,257,299 | |
| 139,405,099 | |
| 136,243,733 | |
| 120,200,000 | |
| 67,550,000 | |
| 14,900,000 | |
| 19,850,000 | |
| 24,800,000 | |
| 16,450,000 | |
| 8,100,000 | |
| 1,150,000 | |
| -5,800,000 | |
| -5,550,000 | |
| -5,300,000 | |
| -5,850,000 | |
| -6,400,000 | |
| -6,000,000 | |
| -5,600,000 | |
| -5,300,000 | |
| -5,000,000 | |
| -4,750,000 | |
| -4,500,000 | |
| -4,950,000 | |
| -3,600,000 | |
| -3,400,000 | |
| -3,200,000 | |
| -2,200,000 | |
| -3,000,000 |